v3.25.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
RETAINED EARNINGS
ACCUMULATED OTHER COMPREHENSIVE LOSS
TREASURY SHARES
NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2023   $ 561 $ 1,242 $ 22,759 $ (5,295) $ (7,076) $ 179
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (125)        
Issuance of shares under stock compensation plans and employee stock purchase plans     80     234  
Net income $ 2,564     2,525     39
Dividend equivalents declared       (7)      
Dividends declared       (699)      
Other comprehensive income (loss), net of tax (232)       (232)    
Purchase of treasury shares (600)         (600)  
Distributions and other changes             (20)
Balance, end of period at Jun. 30, 2024 $ 13,565   1,197 24,578 (5,527) (7,442) 198
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.42            
Balance, beginning of period at Mar. 31, 2024   561 1,112 23,456 (5,509) (7,198) 200
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     80        
Issuance of shares under stock compensation plans and employee stock purchase plans     5     56  
Net income $ 1,140     1,125     15
Dividend equivalents declared       (2)      
Dividends declared       (1)      
Other comprehensive income (loss), net of tax (18)       (18)    
Purchase of treasury shares           (300)  
Distributions and other changes             (17)
Balance, end of period at Jun. 30, 2024 $ 13,565   1,197 24,578 (5,527) (7,442) 198
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 0            
Balance, beginning of period at Dec. 31, 2024 $ 13,535 561 1,370 25,306 (6,240) (7,655) 193
Balance, end of period at Mar. 31, 2025   561 1,253 25,881 (5,896) (7,734) 203
Balance, beginning of period at Dec. 31, 2024 13,535 561 1,370 25,306 (6,240) (7,655) 193
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (131)        
Issuance of shares under stock compensation plans and employee stock purchase plans     123     255  
Net income 2,643     2,592     51
Dividend equivalents declared       (8)      
Dividends declared       (802)      
Other comprehensive income (loss), net of tax 996       996    
Purchase of treasury shares (600)         (600)  
Distributions and other changes             (35)
Balance, end of period at Jun. 30, 2025 $ 15,976   1,362 27,088 (5,244) (8,000) 209
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.63            
Balance, beginning of period at Mar. 31, 2025   $ 561 1,253 25,881 (5,896) (7,734) 203
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     95        
Issuance of shares under stock compensation plans and employee stock purchase plans     14     34  
Net income $ 1,231     1,211     20
Dividend equivalents declared       (3)      
Dividends declared       (1)      
Other comprehensive income (loss), net of tax 652       652    
Purchase of treasury shares           (300)  
Distributions and other changes             (14)
Balance, end of period at Jun. 30, 2025 $ 15,976   $ 1,362 $ 27,088 $ (5,244) $ (8,000) $ 209
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 0